India, Oct. 14 -- To strengthen India's clinical research capabilities and expand the country's participation in global clinical trials, National Institute of Pharmaceutical Education and Research (NIPER), Raebareli, and AstraZeneca India have partnered to extend clinical trial capabilities beyond the metros, building a trained workforce and inspection-ready sites in 25 emerging research geographies across India.

The MoU was signed in the presence of Manoj Joshi, Secretary, Department of Pharmaceuticals, Ministry of Chemicals and Fertilisers in New Delhi today.

This collaboration furthers the vision of Biopharma SHAKTI, the Government of India's flagship initiative to build a stronger biopharma ecosystem, including setting up 1,000 clin...